Testosterone treatment in the aging male: myth or reality?

被引:39
作者
Nigro, Nicole [1 ]
Christ-Crain, Mirjam [1 ]
机构
[1] Univ Basel Hosp, Dept Endocrinol, CH-4031 Basel, Switzerland
关键词
late onset hypogonadism; testosterone replacement therapy; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIALS; LATE-ONSET HYPOGONADISM; LOW SERUM TESTOSTERONE; OLDER MEN; BODY-COMPOSITION; SEXUAL FUNCTION; ELDERLY-MEN; ANDROGEN DEFICIENCY; REPLACEMENT THERAPY;
D O I
10.4414/smw.2012.13539
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The definition of late onset hypogonadism in the aging male is controversially debated, and according to the latest literature consists of at least three especially sexual symptoms such as loss of morning erection, low sexual desire and erectile dysfunction as well as a total testosterone <8-11 nmol/l. Testosterone replacement therapy in the aging male has been shown to have a beneficial effect on muscle and fat mass as well as on bone mineral density, with more conflicting effects observed on muscle strength, sexual function, mood and quality of life. The prescriptions for testosterone products for the aging male increased by over 170% in the previous five years. Furthermore, there is a lot of epidemiological data showing an inverse relationship between testosterone levels and obesity, insulin resistance, the metabolic syndrome and type 2 diabetes mellitus. However, only few small randomised placebo-controlled studies have investigated the effect of testosterone replacement therapy on insulin resistance and HbA1c levels, with controversial results. Importantly, so far the long-term safety and efficacy of testosterone replacement therapy has not been established. Although until now no clear evidence has been found that testosterone replacement therapy has a causative role in prostate cancer or indeed in changes of the biology of the prostate, in a recent meta-analysis a 4-fold increased risk of prostate-associated event rates in testosterone treated elderly men sounds a note of caution. Also the risk for cardiovascular events is still not clear and caution is warranted especially in elderly men with cardiovascular disease and limited mobility. In summary, the actual available evidence of long-term risks and outcome of testosterone replacement therapy is still very limited and carefully designed placebo-controlled trials of testosterone administration to assess the risks and benefits of such a therapy are required. Until then, testosterone treatment in elderly men should be restricted to elderly men with clearly low testosterone levels in the presence of clinical symptoms, and the advantages and disadvantages need to be accurately weighted. A careful monitoring of potential side effects is necessary.
引用
收藏
页数:6
相关论文
共 55 条
[1]  
American Diabetes Association, 1998, DIABETES CARE, V21, P310
[2]  
[Anonymous], 2012, DIABETES CARE S1, V35, P11
[3]   Sex steroids and all-cause and cause-specific mortality in men [J].
Araujo, Andre B. ;
Kupelian, Varant ;
Page, Stephanie T. ;
Handelsman, David J. ;
Bremner, William J. ;
McKinlay, John B. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (12) :1252-1260
[4]   Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis [J].
Araujo, Andre B. ;
Dixon, Julia M. ;
Suarez, Elizabeth A. ;
Murad, M. Hassan ;
Guey, Lin T. ;
Wittert, Gary A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (10) :3007-3019
[5]   Sexual function in men older than 50 years of age: Results from the health professionals follow-up study [J].
Bacon, CG ;
Mittleman, MA ;
Kawachi, I ;
Giovannucci, E ;
Glasser, DB ;
Rimm, EB .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (03) :161-168
[6]   Testosterone improves rehabilitation outcomes in ill older men [J].
Bakhshi, V ;
Elliott, M ;
Gentili, A ;
Godschalk, M ;
Mulligan, T .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (05) :550-553
[7]   Adverse Events Associated with Testosterone Administration [J].
Basaria, Shehzad ;
Coviello, Andrea D. ;
Travison, Thomas G. ;
Storer, Thomas W. ;
Farwell, Wildon R. ;
Jette, Alan M. ;
Eder, Richard ;
Tennstedt, Sharon ;
Ulloor, Jagadish ;
Zhang, Anqi ;
Choong, Karen ;
Lakshman, Kishore M. ;
Mazer, Norman A. ;
Miciek, Renee ;
Krasnoff, Joanne ;
Elmi, Ayan ;
Knapp, Philip E. ;
Brooks, Brad ;
Appleman, Erica ;
Aggarwal, Sheetal ;
Bhasin, Geeta ;
Hede-Brierley, Leif ;
Bhatia, Ashmeet ;
Collins, Lauren ;
LeBrasseur, Nathan ;
Fiore, Louis D. ;
Bhasin, Shalender .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (02) :109-122
[8]   Deterioration of trabecular architecture in hypogonadal men [J].
Benito, M ;
Gomberg, B ;
Wehrli, FW ;
Weening, RH ;
Zemel, B ;
Wright, AC ;
Song, HK ;
Cucchiara, A ;
Snyder, PJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) :1497-1502
[9]   Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline [J].
Bhasin, Shalender ;
Cunningham, Glenn R. ;
Hayes, Frances J. ;
Matsumoto, Alvin M. ;
Snyder, Peter J. ;
Swerdloff, Ronald S. ;
Montori, Victor M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (06) :2536-2559
[10]   Testosterone use in men with sexual dysfunction:: A systematic review and meta-analysis of randomized placebo-controlled trials [J].
Bolona, Enrique R. ;
Uraga, Maria V. ;
Haddad, Rudy M. ;
Tracz, Michal J. ;
Sideras, Kostandinos ;
Kennedy, Cassie C. ;
Caples, Sean M. ;
Erwin, Patricia J. ;
Montori, Victor M. .
MAYO CLINIC PROCEEDINGS, 2007, 82 (01) :20-28